O	O	O	0	11	Cyclosporin	Cyclosporin	B-NP	NN	O	2	NMOD	O
O	O	O	12	13	A	A	I-NP	NN	O	3	SUB	O
O	O	O	14	22	inhibits	inhibit	B-VP	VBZ	O	0	ROOT	O
O	O	O	23	28	early	early	B-NP	JJ	O	6	NMOD	O
O	O	O	29	33	mRNA	mRNA	I-NP	NN	O	6	NMOD	O
O	O	O	34	44	expression	expression	I-NP	NN	O	3	OBJ	O
O	O	O	45	47	of	of	B-PP	IN	O	6	NMOD	O
T1	B-Protein	B-Protein	48	50	G0	G0	B-NP	NN	O	7	PMOD	O
T1	I-Protein	I-Protein	50	51	/	/	B-NP	SYM	O	8	NMOD	O
T1	I-Protein	I-Protein	51	53	G1	G1	I-NP	NN	B-DNA	12	NMOD	B-DNA
T1	I-Protein	I-Protein	54	60	switch	switch	I-NP	NN	I-DNA	12	NMOD	I-DNA
T1	I-Protein	I-Protein	61	65	gene	gene	I-NP	NN	I-DNA	9	PMOD	I-DNA
T1	I-Protein	I-Protein	66	67	2	2	I-NP	CD	I-DNA	12	NMOD	I-DNA
O	O	O	68	69	(	(	O	(	O	16	DEP	O
T2	B-Protein	B-Protein	69	73	G0S2	G0S2	B-NP	NN	B-DNA	16	DEP	B-DNA
O	O	O	73	74	)	)	O	)	O	12	NMOD	O
O	O	O	75	77	in	in	B-PP	IN	O	12	NMOD	O
O	O	O	78	86	cultured	culture	B-NP	VBN	B-cell_line	22	NMOD	B-cell_line
O	O	O	87	92	human	human	I-NP	JJ	I-cell_line	22	NMOD	I-cell_line
O	O	O	93	98	blood	blood	I-NP	NN	I-cell_line	22	NMOD	I-cell_line
O	O	O	99	110	mononuclear	mononuclear	I-NP	JJ	I-cell_line	22	NMOD	I-cell_line
O	O	O	111	116	cells	cell	I-NP	NNS	I-cell_line	17	PMOD	I-cell_line
O	O	O	116	117	.	.	O	.	O	3	P	O

O	O	O	119	130	Cyclosporin	Cyclosporin	B-NP	NN	O	2	NMOD	O
O	O	O	131	132	A	A	I-NP	NN	O	6	SUB	O
O	O	O	133	134	(	(	O	(	O	5	DEP	O
O	O	O	134	137	CsA	CsA	B-NP	NN	O	5	DEP	O
O	O	O	137	138	)	)	O	)	O	2	NMOD	O
O	O	O	139	142	may	may	B-VP	MD	O	0	ROOT	O
O	O	O	143	150	achieve	achieve	I-VP	VB	O	6	VC	O
O	O	O	151	154	its	its	B-NP	PRP$	O	10	NMOD	O
O	O	O	155	172	immunosuppressive	immunosuppressive	I-NP	JJ	O	10	NMOD	O
O	O	O	173	180	effects	effect	I-NP	NNS	O	7	OBJ	O
O	O	O	181	183	by	by	B-PP	IN	O	7	VMOD	O
O	O	O	184	194	inhibiting	inhibit	B-VP	VBG	O	11	PMOD	O
O	O	O	195	198	the	the	B-NP	DT	O	14	NMOD	O
O	O	O	199	206	calcium	calcium	I-NP	NN	O	21	NMOD	O
O	O	O	206	207	-	-	B-NP	HYPH	O	14	P	O
O	O	O	208	211	and	and	I-NP	CC	O	21	NMOD	O
O	O	O	212	222	calmodulin	calmodulin	I-NP	NN	B-protein	21	NMOD	B-protein
O	O	O	222	223	-	-	I-NP	HYPH	O	21	P	O
O	O	O	223	232	dependent	dependent	I-NP	JJ	O	21	NMOD	O
O	O	O	233	244	phosphatase	phosphatase	I-NP	NN	O	21	NMOD	O
O	O	O	245	256	calcineurin	calcineurin	I-NP	NN	B-protein	12	OBJ	B-protein
O	O	O	257	262	which	which	B-NP	WDT	O	21	NMOD	O
O	O	O	263	265	is	be	B-VP	VBZ	O	22	SBAR	O
O	O	O	266	274	required	require	I-VP	VBN	O	23	VC	O
O	O	O	275	278	for	for	B-PP	IN	O	24	VMOD	O
O	O	O	279	289	activation	activation	B-NP	NN	O	25	PMOD	O
O	O	O	290	292	of	of	B-PP	IN	O	26	NMOD	O
T15	B-Entity	B-Entity	293	299	target	target	B-NP	NN	B-DNA	29	NMOD	B-DNA
T15	I-Entity	I-Entity	300	305	genes	gene	I-NP	NNS	I-DNA	27	PMOD	I-DNA
O	O	O	306	308	by	by	B-PP	IN	O	26	NMOD	O
O	O	O	309	316	members	member	B-NP	NNS	O	30	PMOD	O
O	O	O	317	319	of	of	B-PP	IN	O	31	NMOD	O
O	O	O	320	323	the	the	B-NP	DT	O	45	NMOD	O
O	O	O	324	328	NFAT	NFAT	I-NP	NN	B-protein	45	NMOD	B-protein
O	O	O	329	330	(	(	O	(	I-protein	45	NMOD	I-protein
O	O	O	330	337	nuclear	nuclear	B-NP	JJ	I-protein	45	NMOD	I-protein
O	O	O	338	344	factor	factor	I-NP	NN	I-protein	45	NMOD	I-protein
O	O	O	345	347	of	of	B-PP	IN	I-protein	45	NMOD	I-protein
O	O	O	348	357	activated	activate	B-NP	VBN	I-protein	45	NMOD	I-protein
O	O	O	358	359	T	T	I-NP	NN	I-protein	45	NMOD	I-protein
O	O	O	360	365	cells	cell	I-NP	NNS	I-protein	45	NMOD	I-protein
O	O	O	365	366	)	)	O	)	I-protein	45	NMOD	I-protein
O	O	O	367	380	transcription	transcription	B-NP	NN	I-protein	45	NMOD	I-protein
O	O	O	381	387	factor	factor	I-NP	NN	I-protein	45	NMOD	I-protein
O	O	O	388	394	family	family	I-NP	NN	I-protein	32	PMOD	I-protein
O	O	O	394	395	.	.	O	.	O	6	P	O

O	O	O	396	401	Among	Among	B-PP	IN	O	5	PRD	O
O	O	O	402	407	these	these	B-NP	DT	O	4	NMOD	O
T16	B-Entity	B-Entity	408	414	target	target	I-NP	NN	B-DNA	4	NMOD	B-DNA
T16	I-Entity	I-Entity	415	420	genes	gene	I-NP	NNS	I-DNA	1	PMOD	I-DNA
O	O	O	421	423	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	424	427	the	the	B-NP	DT	O	7	NMOD	O
O	O	O	428	432	gene	gene	I-NP	NN	O	5	PRD	O
O	O	O	433	441	encoding	encode	B-VP	VBG	O	7	NMOD	O
T3	B-Protein	B-Protein	442	453	interleukin	interleukin	B-NP	NN	B-protein	17	NMOD	B-protein
T3	I-Protein	I-Protein	453	454	-	-	O	HYPH	I-protein	9	NMOD	I-protein
T3	I-Protein	I-Protein	454	455	2	2	B-NP	CD	I-protein	9	NMOD	I-protein
O	O	O	456	457	(	(	O	(	O	14	DEP	O
T4	B-Protein	B-Protein	457	460	IL2	IL2	B-NP	NN	B-protein	14	DEP	B-protein
O	O	O	460	461	)	)	O	)	O	9	NMOD	O
O	O	O	461	462	,	,	O	,	O	17	P	O
O	O	O	463	464	a	a	B-NP	DT	O	17	NMOD	O
O	O	O	465	473	cytokine	cytokine	I-NP	NN	B-protein	8	OBJ	B-protein
O	O	O	474	486	facilitating	facilitate	B-VP	VBG	O	17	NMOD	O
O	O	O	487	498	progression	progression	B-NP	NN	O	18	OBJ	O
O	O	O	499	506	through	through	B-PP	IN	O	19	NMOD	O
O	O	O	507	510	the	the	B-NP	DT	O	23	NMOD	O
O	O	O	511	513	G1	G1	I-NP	NN	O	23	NMOD	O
O	O	O	514	519	phase	phase	I-NP	NN	O	20	PMOD	O
O	O	O	520	522	of	of	B-PP	IN	O	23	NMOD	O
O	O	O	523	526	the	the	B-NP	DT	O	27	NMOD	O
O	O	O	527	531	cell	cell	I-NP	NN	O	27	NMOD	O
O	O	O	532	537	cycle	cycle	I-NP	NN	O	24	PMOD	O
O	O	O	537	538	.	.	O	.	O	5	P	O

O	O	O	539	546	However	However	B-ADVP	RB	O	4	VMOD	O
O	O	O	546	547	,	,	O	,	O	4	P	O
T5	B-Protein	B-Protein	548	551	IL2	IL2	B-NP	NN	B-protein	4	SUB	B-protein
O	O	O	552	556	does	do	B-VP	VBZ	O	0	ROOT	O
O	O	O	557	560	not	not	I-VP	RB	O	4	VMOD	O
O	O	O	561	568	reverse	reverse	I-VP	VB	O	4	VC	O
O	O	O	569	572	CsA	CsA	B-NP	NN	O	8	NMOD	O
O	O	O	573	583	inhibition	inhibition	I-NP	NN	O	6	OBJ	O
O	O	O	583	584	,	,	O	,	O	4	P	O
O	O	O	585	595	suggesting	suggest	B-VP	VBG	O	4	VMOD	O
O	O	O	596	600	that	that	B-SBAR	IN	O	10	VMOD	O
O	O	O	601	603	at	at	B-NP	IN	O	20	SUB	O
O	O	O	604	609	least	least	I-NP	JJS	O	12	AMOD	O
O	O	O	610	613	one	one	I-NP	CD	O	12	AMOD	O
O	O	O	614	619	other	other	I-NP	JJ	O	19	NMOD	O
T17	B-Entity	B-Entity	620	624	NFAT	NFAT	I-NP	NN	B-protein	19	NMOD	B-protein
T17	I-Entity	I-Entity	624	625	-	-	B-NP	HYPH	O	19	NMOD	O
T17	I-Entity	I-Entity	625	634	sensitive	sensitive	I-NP	JJ	O	19	NMOD	O
T17	I-Entity	I-Entity	635	639	gene	gene	I-NP	NN	O	12	SUB	O
O	O	O	640	643	may	may	B-VP	MD	O	11	SBAR	O
O	O	O	644	646	be	be	I-VP	VB	O	20	VC	O
O	O	O	647	655	involved	involve	I-VP	VBN	O	21	VC	O
O	O	O	655	656	.	.	O	.	O	4	P	O

O	O	O	657	660	The	The	B-NP	DT	O	9	NMOD	O
O	O	O	661	666	human	human	I-NP	JJ	B-DNA	7	NMOD	B-DNA
T6	B-Protein	B-Protein	667	669	G0	G0	I-NP	NN	I-DNA	7	NMOD	I-DNA
T6	I-Protein	I-Protein	669	670	/	/	B-NP	SYM	I-DNA	7	NMOD	I-DNA
T6	I-Protein	I-Protein	670	672	G1	G1	I-NP	NN	I-DNA	7	NMOD	I-DNA
T6	I-Protein	I-Protein	673	679	switch	switch	I-NP	NN	I-DNA	7	NMOD	I-DNA
T6	I-Protein	I-Protein	680	684	gene	gene	I-NP	NN	I-DNA	9	NMOD	I-DNA
O	O	O	684	685	,	,	O	,	O	9	P	O
T7	B-Protein	B-Protein	686	690	G0S2	G0S2	B-NP	NN	B-DNA	11	SUB	B-DNA
O	O	O	690	691	,	,	O	,	O	9	P	O
O	O	O	692	695	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	O	696	705	potential	potential	B-NP	JJ	O	11	OBJ	O
T18	B-Entity	B-Entity	706	710	NFAT	NFAT	I-NP	NN	B-protein	12	NMOD	B-protein
T18	I-Entity	I-Entity	710	711	-	-	B-VP	HYPH	O	12	P	O
T18	I-Entity	I-Entity	711	718	binding	bind	B-NP	VBG	B-DNA	16	NMOD	B-DNA
T18	I-Entity	I-Entity	719	724	sites	site	I-NP	NNS	I-DNA	12	NMOD	I-DNA
O	O	O	725	727	in	in	B-PP	IN	O	11	VMOD	O
O	O	O	728	731	the	the	B-NP	DT	O	21	NMOD	O
T19	B-Entity	B-Entity	732	733	5	5	I-NP	CD	B-DNA	21	NMOD	B-DNA
T19	I-Entity	I-Entity	733	734	'	'	I-NP	SYM	I-DNA	21	NMOD	I-DNA
T19	I-Entity	I-Entity	735	740	flank	flank	I-NP	NN	I-DNA	17	PMOD	I-DNA
O	O	O	741	744	and	and	O	CC	O	11	VMOD	O
O	O	O	745	752	encodes	encode	B-VP	VBZ	O	11	VMOD	O
O	O	O	753	754	a	a	B-NP	DT	O	28	NMOD	O
O	O	O	755	760	small	small	I-NP	JJ	B-protein	28	NMOD	B-protein
O	O	O	761	766	basic	basic	I-NP	JJ	I-protein	28	NMOD	I-protein
O	O	O	767	776	potential	potential	I-NP	JJ	I-protein	28	NMOD	I-protein
O	O	O	777	791	phosphoprotein	phosphoprotein	I-NP	NN	I-protein	23	OBJ	I-protein
O	O	O	792	794	of	of	B-PP	IN	O	28	NMOD	O
O	O	O	795	802	unknown	unknown	B-NP	JJ	O	31	NMOD	O
O	O	O	803	811	function	function	I-NP	NN	O	29	PMOD	O
O	O	O	811	812	.	.	O	.	O	11	P	O

O	O	O	813	818	Using	Use	B-VP	VBG	O	21	VMOD	O
O	O	O	819	820	a	a	B-NP	DT	O	6	NMOD	O
O	O	O	821	830	sensitive	sensitive	I-NP	JJ	O	5	AMOD	O
O	O	O	830	831	,	,	I-NP	,	O	5	P	O
O	O	O	832	839	reverse	reverse	I-NP	JJ	O	6	NMOD	O
O	O	O	840	853	transcription	transcription	I-NP	NN	O	10	NMOD	O
O	O	O	853	854	-	-	B-NP	HYPH	O	10	NMOD	O
O	O	O	854	864	polymerase	polymerase	I-NP	NN	O	10	NMOD	O
O	O	O	865	870	chain	chain	I-NP	NN	O	10	NMOD	O
O	O	O	871	879	reaction	reaction	I-NP	NN	O	16	NMOD	O
O	O	O	880	881	(	(	O	(	O	15	DEP	O
O	O	O	881	883	RT	RT	B-NP	NN	O	14	NMOD	O
O	O	O	883	884	-	-	B-NP	HYPH	O	14	P	O
O	O	O	884	887	PCR	PCR	I-NP	NN	O	15	DEP	O
O	O	O	887	888	)	)	O	)	O	10	NMOD	O
O	O	O	889	894	assay	assay	B-NP	NN	O	1	OBJ	O
O	O	O	894	895	,	,	O	,	O	21	P	O
T8	B-Protein	B-Protein	896	900	G0S2	G0S2	B-NP	NN	B-RNA	20	NMOD	B-RNA
O	O	O	901	905	mRNA	mRNA	I-NP	NN	I-RNA	20	NMOD	I-RNA
O	O	O	906	912	levels	level	I-NP	NNS	O	21	SUB	O
O	O	O	913	917	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	918	925	assayed	assay	I-VP	VBN	O	21	VC	O
O	O	O	926	928	in	in	B-PP	IN	O	22	VMOD	O
O	O	O	929	937	cultured	culture	B-NP	VBN	B-cell_type	27	NMOD	B-cell_type
O	O	O	938	943	blood	blood	I-NP	NN	I-cell_type	27	NMOD	I-cell_type
O	O	O	944	955	mononuclear	mononuclear	I-NP	JJ	I-cell_type	27	NMOD	I-cell_type
O	O	O	956	961	cells	cell	I-NP	NNS	I-cell_type	23	PMOD	I-cell_type
O	O	O	961	962	.	.	O	.	O	21	P	O

O	O	O	963	970	Freshly	Freshly	B-NP	RB	O	2	AMOD	O
O	O	O	971	979	isolated	isolate	I-NP	VBN	O	3	NMOD	O
O	O	O	980	985	cells	cell	I-NP	NNS	O	4	SUB	O
O	O	O	986	993	contain	contain	B-VP	VBP	O	0	ROOT	O
O	O	O	994	998	high	high	B-NP	JJ	O	6	NMOD	O
O	O	O	999	1005	levels	level	I-NP	NNS	O	4	OBJ	O
O	O	O	1006	1008	of	of	B-PP	IN	O	6	NMOD	O
T9	B-Protein	B-Protein	1009	1013	G0S2	G0S2	B-NP	NN	B-RNA	9	NMOD	B-RNA
O	O	O	1014	1018	mRNA	mRNA	I-NP	NN	I-RNA	7	PMOD	I-RNA
O	O	O	1019	1024	which	which	B-NP	WDT	O	6	NMOD	O
O	O	O	1025	1032	rapidly	rapidly	B-ADVP	RB	O	12	VMOD	O
O	O	O	1033	1040	decline	decline	B-VP	VBP	O	10	SBAR	O
O	O	O	1040	1041	.	.	O	.	O	4	P	O

O	O	O	1042	1046	This	This	B-NP	DT	O	4	NMOD	O
O	O	O	1047	1048	"	"	I-NP	``	B-DNA	4	NMOD	B-DNA
O	O	O	1048	1059	spontaneous	spontaneous	I-NP	JJ	I-DNA	4	NMOD	I-DNA
O	O	O	1060	1071	stimulation	stimulation	I-NP	NN	I-DNA	6	SUB	I-DNA
O	O	O	1071	1072	"	"	O	''	I-DNA	4	NMOD	I-DNA
O	O	O	1073	1075	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	1076	1080	also	also	I-VP	RB	O	6	VMOD	O
O	O	O	1081	1086	noted	note	I-VP	VBN	O	6	VC	O
O	O	O	1087	1091	with	with	B-PP	IN	O	8	VMOD	O
O	O	O	1092	1096	some	some	B-NP	DT	O	11	NMOD	O
O	O	O	1097	1102	other	other	I-NP	JJ	O	9	PMOD	O
T10	B-Protein	B-Protein	1103	1106	G0S	G0S	I-NP	NN	B-DNA	13	NMOD	B-DNA
O	O	O	1107	1112	genes	gene	I-NP	NNS	I-DNA	11	NMOD	I-DNA
O	O	O	1113	1116	and	and	O	CC	O	6	VMOD	O
O	O	O	1117	1120	has	have	B-VP	VBZ	O	6	VMOD	O
O	O	O	1121	1125	been	be	I-VP	VBN	O	15	VC	O
O	O	O	1126	1136	attributed	attribute	I-VP	VBN	O	16	VC	O
O	O	O	1137	1139	to	to	B-PP	TO	O	17	VMOD	O
O	O	O	1140	1144	some	some	B-NP	DT	O	20	NMOD	O
O	O	O	1145	1151	aspect	aspect	I-NP	NN	O	18	PMOD	O
O	O	O	1152	1154	of	of	B-PP	IN	O	20	NMOD	O
O	O	O	1155	1158	the	the	B-NP	DT	O	24	NMOD	O
O	O	O	1159	1168	isolation	isolation	I-NP	NN	O	24	NMOD	O
O	O	O	1169	1178	procedure	procedure	I-NP	NN	O	21	PMOD	O
O	O	O	1178	1179	.	.	O	.	O	6	P	O

O	O	O	1180	1182	In	In	B-PP	IN	O	13	VMOD	O
O	O	O	1183	1188	cells	cell	B-NP	NNS	O	1	PMOD	O
O	O	O	1189	1193	that	that	B-NP	WDT	O	2	NMOD	O
O	O	O	1194	1198	have	have	B-VP	VBP	O	3	SBAR	O
O	O	O	1199	1203	been	be	I-VP	VBN	O	4	VC	O
O	O	O	1204	1216	preincubated	preincubate	I-VP	VBN	O	5	VC	O
O	O	O	1217	1219	to	to	I-VP	TO	O	8	VMOD	O
O	O	O	1220	1225	lower	lower	I-VP	VB	O	6	VC	O
O	O	O	1226	1230	mRNA	mRNA	B-NP	NN	B-RNA	10	NMOD	B-RNA
O	O	O	1231	1237	levels	level	I-NP	NNS	O	8	OBJ	O
O	O	O	1237	1238	,	,	O	,	O	13	P	O
O	O	O	1239	1244	there	there	B-NP	EX	O	13	SUB	O
O	O	O	1245	1247	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	1248	1249	a	a	B-NP	DT	O	16	NMOD	O
O	O	O	1250	1259	transient	transient	I-NP	JJ	O	16	NMOD	O
O	O	O	1260	1268	increase	increase	I-NP	NN	O	13	PRD	O
O	O	O	1269	1271	in	in	B-PP	IN	O	16	NMOD	O
T11	B-Protein	B-Protein	1272	1276	G0S2	G0S2	B-NP	NN	B-RNA	19	NMOD	B-RNA
O	O	O	1277	1281	mRNA	mRNA	I-NP	NN	I-RNA	17	PMOD	I-RNA
O	O	O	1281	1282	,	,	O	,	O	16	P	O
O	O	O	1283	1290	peaking	peak	B-VP	VBG	O	16	NMOD	O
O	O	O	1291	1298	between	between	B-NP	IN	O	21	VMOD	O
O	O	O	1299	1300	1	1	I-NP	CD	O	22	AMOD	O
O	O	O	1300	1301	-	-	I-NP	HYPH	O	22	P	O
O	O	O	1301	1302	2	2	I-NP	CD	O	22	AMOD	O
O	O	O	1303	1304	h	h	I-NP	NN	O	22	PMOD	O
O	O	O	1304	1305	,	,	O	,	O	16	P	O
O	O	O	1306	1308	in	in	B-PP	IN	O	16	NMOD	O
O	O	O	1309	1317	response	response	I-PP	NN	O	28	PMOD	O
O	O	O	1318	1320	to	to	I-PP	TO	O	28	PMOD	O
O	O	O	1321	1333	Concanavalin	Concanavalin	O	NN	O	54	NMOD	O
O	O	O	1333	1334	-	-	O	HYPH	O	54	NMOD	O
O	O	O	1334	1335	A	A	B-NP	NN	O	54	NMOD	O
O	O	O	1336	1337	(	(	O	(	O	36	DEP	O
O	O	O	1337	1341	ConA	ConA	B-NP	NN	O	36	DEP	O
O	O	O	1341	1342	)	)	O	)	O	33	NMOD	O
O	O	O	1342	1343	,	,	O	,	O	33	P	O
O	O	O	1344	1346	or	or	O	CC	O	54	NMOD	O
O	O	O	1347	1349	to	to	B-PP	TO	O	54	NMOD	O
O	O	O	1350	1353	the	the	B-NP	DT	O	41	NMOD	O
O	O	O	1354	1365	combination	combination	I-NP	NN	O	39	PMOD	O
O	O	O	1366	1368	of	of	B-PP	IN	O	41	NMOD	O
O	O	O	1369	1376	phorbol	phorbol	B-NP	NN	O	44	NMOD	O
O	O	O	1377	1382	ester	ester	I-NP	NN	O	42	PMOD	O
O	O	O	1383	1384	(	(	O	(	O	47	DEP	O
O	O	O	1384	1387	TPA	TPA	B-NP	NN	O	47	DEP	O
O	O	O	1387	1388	)	)	O	)	O	44	NMOD	O
O	O	O	1388	1389	,	,	O	,	O	54	P	O
O	O	O	1390	1393	and	and	O	CC	O	54	NMOD	O
O	O	O	1394	1397	the	the	B-NP	DT	O	52	NMOD	O
O	O	O	1398	1405	calcium	calcium	I-NP	NN	O	52	NMOD	O
O	O	O	1406	1415	ionophore	ionophore	I-NP	NN	O	54	NMOD	O
O	O	O	1415	1416	,	,	O	,	O	54	P	O
O	O	O	1417	1426	ionomycin	ionomycin	B-NP	NN	O	28	PMOD	O
O	O	O	1426	1427	.	.	O	.	O	13	P	O

O	O	O	1428	1432	Both	Both	B-NP	DT	O	3	NMOD	O
O	O	O	1433	1438	these	these	B-NP	DT	O	3	NMOD	O
O	O	O	1439	1448	responses	response	I-NP	NNS	O	4	SUB	O
O	O	O	1449	1452	are	be	B-VP	VBP	O	0	ROOT	O
O	O	O	1453	1462	inhibited	inhibit	I-VP	VBN	O	4	VC	O
O	O	O	1463	1465	by	by	B-PP	IN	O	5	VMOD	O
O	O	O	1466	1469	CsA	CsA	B-NP	NN	O	6	PMOD	O
O	O	O	1469	1470	.	.	O	.	O	4	P	O

O	O	O	1471	1474	Our	Our	B-NP	PRP$	O	2	NMOD	O
O	O	O	1475	1482	results	result	I-NP	NNS	O	3	SUB	O
O	O	O	1483	1490	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	O	1491	1495	that	that	B-SBAR	IN	O	23	DEP	O
T12	B-Protein	B-Protein	1496	1500	G0S2	G0S2	B-NP	NN	B-DNA	6	NMOD	B-DNA
O	O	O	1501	1511	expression	expression	I-NP	NN	O	7	SUB	O
O	O	O	1512	1514	is	be	B-VP	VBZ	O	4	SBAR	O
O	O	O	1515	1523	required	require	I-VP	VBN	O	7	VC	O
O	O	O	1524	1526	to	to	I-VP	TO	O	10	VMOD	O
O	O	O	1527	1533	commit	commit	I-VP	VB	O	7	VMOD	O
O	O	O	1534	1539	cells	cell	B-NP	NNS	O	13	SUB	O
O	O	O	1540	1542	to	to	B-VP	TO	O	13	VMOD	O
O	O	O	1543	1548	enter	enter	I-VP	VB	O	10	VMOD	O
O	O	O	1549	1552	the	the	B-NP	DT	O	16	NMOD	O
O	O	O	1553	1555	G1	G1	I-NP	NN	O	16	NMOD	O
O	O	O	1556	1561	phase	phase	I-NP	NN	O	13	OBJ	O
O	O	O	1562	1564	of	of	B-PP	IN	O	16	NMOD	O
O	O	O	1565	1568	the	the	B-NP	DT	O	20	NMOD	O
O	O	O	1569	1573	cell	cell	I-NP	NN	O	20	NMOD	O
O	O	O	1574	1579	cycle	cycle	I-NP	NN	O	17	PMOD	O
O	O	O	1579	1580	,	,	O	,	O	23	P	O
O	O	O	1581	1584	and	and	O	CC	O	23	DEP	O
O	O	O	1585	1589	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	1589	1590	,	,	O	,	O	23	P	O
O	O	O	1591	1596	while	while	B-SBAR	IN	O	39	VMOD	O
O	O	O	1597	1600	not	not	B-VP	RB	O	27	VMOD	O
O	O	O	1601	1610	excluding	exclude	I-VP	VBG	O	25	SBAR	O
O	O	O	1611	1616	other	other	B-NP	JJ	O	30	NMOD	O
O	O	O	1617	1625	possible	possible	I-NP	JJ	O	30	NMOD	O
O	O	O	1626	1633	targets	target	I-NP	NNS	O	27	OBJ	O
O	O	O	1633	1634	,	,	O	,	O	39	P	O
O	O	O	1635	1640	early	early	B-NP	JJ	O	33	NMOD	O
O	O	O	1641	1651	inhibition	inhibition	I-NP	NN	O	39	SUB	O
O	O	O	1652	1654	of	of	B-PP	IN	O	33	NMOD	O
T13	B-Protein	B-Protein	1655	1659	G0S2	G0S2	B-NP	NN	B-DNA	36	NMOD	B-DNA
O	O	O	1660	1670	expression	expression	I-NP	NN	O	34	PMOD	O
O	O	O	1671	1673	by	by	B-PP	IN	O	33	NMOD	O
O	O	O	1674	1677	CsA	CsA	B-NP	NN	O	37	PMOD	O
O	O	O	1678	1681	may	may	B-VP	MD	O	23	SBAR	O
O	O	O	1682	1684	be	be	I-VP	VB	O	39	VC	O
O	O	O	1685	1694	important	important	B-ADJP	JJ	O	40	PRD	O
O	O	O	1695	1697	in	in	B-PP	IN	O	41	AMOD	O
O	O	O	1698	1707	achieving	achieve	B-VP	VBG	O	42	PMOD	O
O	O	O	1708	1725	immunosuppression	immunosuppression	B-NP	NN	O	43	OBJ	O
O	O	O	1725	1726	.	.	O	.	O	3	P	O

T14	B-Protein	B-Protein	1727	1731	G0S2	G0S2	B-NP	NN	B-DNA	2	SUB	B-DNA
O	O	O	1732	1735	may	may	B-VP	MD	O	0	ROOT	O
O	O	O	1736	1738	be	be	I-VP	VB	O	2	VC	O
O	O	O	1739	1741	of	of	B-PP	IN	O	3	PRD	O
O	O	O	1742	1747	value	value	B-NP	NN	O	4	PMOD	O
O	O	O	1748	1750	as	as	B-PP	IN	O	3	VMOD	O
O	O	O	1751	1752	a	a	B-NP	DT	O	9	NMOD	O
O	O	O	1753	1761	reporter	reporter	I-NP	NN	B-DNA	9	NMOD	B-DNA
O	O	O	1762	1766	gene	gene	I-NP	NN	I-DNA	6	PMOD	I-DNA
O	O	O	1767	1770	for	for	B-PP	IN	O	9	NMOD	O
O	O	O	1771	1780	analyzing	analyze	B-VP	VBG	O	10	PMOD	O
O	O	O	1781	1784	the	the	B-NP	DT	O	13	NMOD	O
O	O	O	1785	1794	mechanism	mechanism	I-NP	NN	O	20	NMOD	O
O	O	O	1795	1797	of	of	B-PP	IN	O	13	NMOD	O
O	O	O	1798	1804	action	action	B-NP	NN	O	14	PMOD	O
O	O	O	1805	1807	of	of	B-PP	IN	O	15	NMOD	O
O	O	O	1808	1811	CsA	CsA	B-NP	NN	O	16	PMOD	O
O	O	O	1812	1815	and	and	O	CC	O	20	NMOD	O
O	O	O	1816	1819	its	its	B-NP	PRP$	O	20	NMOD	O
O	O	O	1820	1829	influence	influence	I-NP	NN	O	11	OBJ	O
O	O	O	1830	1832	on	on	B-PP	IN	O	20	NMOD	O
O	O	O	1833	1836	the	the	B-NP	DT	O	26	NMOD	O
O	O	O	1837	1845	positive	positive	I-NP	JJ	O	26	NMOD	O
O	O	O	1846	1849	and	and	I-NP	CC	O	26	NMOD	O
O	O	O	1850	1858	negative	negative	I-NP	JJ	O	26	NMOD	O
O	O	O	1859	1868	selection	selection	I-NP	NN	O	21	PMOD	O
O	O	O	1869	1871	of	of	B-PP	IN	O	26	NMOD	O
O	O	O	1872	1883	lymphocytes	lymphocyte	B-NP	NNS	B-cell_type	27	PMOD	B-cell_type
O	O	O	1884	1886	in	in	B-PP	IN	O	26	NMOD	O
O	O	O	1887	1895	response	response	B-NP	NN	O	29	PMOD	O
O	O	O	1896	1898	to	to	B-PP	TO	O	30	NMOD	O
O	O	O	1899	1903	self	self	B-NP	NN	O	37	NMOD	O
O	O	O	1904	1907	and	and	O	CC	O	37	NMOD	O
O	O	O	1908	1911	not	not	O	RB	O	37	NMOD	O
O	O	O	1911	1912	-	-	O	HYPH	B-protein	37	NMOD	B-protein
O	O	O	1912	1916	self	self	B-NP	NN	I-protein	37	NMOD	I-protein
O	O	O	1917	1925	antigens	antigen	I-NP	NNS	I-protein	31	PMOD	I-protein
O	O	O	1925	1926	.	.	O	.	O	2	P	O
